Cytogenetic tests: Difference between revisions
Jump to navigation
Jump to search
→ISH: +OMIM |
|||
| Line 20: | Line 20: | ||
| Tx (imatinib) | | Tx (imatinib) | ||
|- | |- | ||
| MLL | | MLL<ref>{{OMIM|159555}}</ref> | ||
| ALL or AML | | ALL or AML | ||
| rearrangment --> marker of poor prognosis<ref>{{Cite journal | last1 = Liedtke | first1 = M. | last2 = Cleary | first2 = ML. | title = Therapeutic targeting of MLL. | journal = Blood | volume = 113 | issue = 24 | pages = 6061-8 | month = Jun | year = 2009 | doi = 10.1182/blood-2008-12-197061 | PMID = 19289854 }} | | rearrangment --> marker of poor prognosis<ref>{{Cite journal | last1 = Liedtke | first1 = M. | last2 = Cleary | first2 = ML. | title = Therapeutic targeting of MLL. | journal = Blood | volume = 113 | issue = 24 | pages = 6061-8 | month = Jun | year = 2009 | doi = 10.1182/blood-2008-12-197061 | PMID = 19289854 }} | ||